Clinical Trials
The Mid-Illinois Medical District is home to healthcare institutions that conduct clinic trials on a regular basis. The work done here provides opportunities for individuals to be involved in ground-breaking discoveries that can, and often do, result in improved quality of care and patient outcomes.
Memorial Medical Center
The Central Illinois Community Clinical Oncology Program (CICCOP) offers innovative treatments for cancer through a grant supported by the National Cancer Institute (NCI). For more about clinical trials offered by the community's oncologists in affiliation with Memorial Medical Center’s Regional Cancer Center, visit https://www.memorialmedical.com/Services/CancerCenter/ClinicalTrials.aspx.
Prairie Education and Research Cooperative (PERC)
www.thepercdifference.com
PERC is a dynamic, professional, experienced Research Organization that was founded in 1983. PERC specializes in all aspects of Clinical Trial Management both locally and nationally, including Research Site and Data Management as well as Independent Auditing. Locally, PERC offers research subjects the opportunity to participate in cutting edge research trials, ranging from cardiac drug and device trials to carotid stent trials. PERC’s staff of medical professionals believes every research subject is a “medical hero,” treated with compassion and respect. To learn more about PERC as well as current enrolling trials, visit our website.
Southern Illinois School of Medicine
http://www.siumed.edu/cancer/researchpages/trials.html
Springfield Clinic, LLP https://www.springfieldclinic.com/Patient_Services/Clinical_Research.asp Research conducted at Springfield Clinic offers patients the opportunity to participate in the development of today's promising new medicines and the latest medical treatments. The experienced, centralized Research Department provides clinical trial services to the 200+ Springfield Clinic providers. With over 30 active trials, we are equipped to provide patients with therapies from the leading edge of medical science and the earliest possible access to promising new medicines and technology.